Filters
Proton pump inhibitor (PPI) co-therapy appears to lower the risk of hospitalization for upper gastrointestinal bleeding (UGIB) in atrial fibrillation (AF) patients receiving direct oral anticoagulant (DOAC) treatment, according to a study from Korea.
Statin therapy appears to mitigate the risk of venous thromboembolism associated with exogenous hormones, according to a study.
A systematic review and meta-analysis of prospective studies demonstrate that switching from animal-based (AB) to plant-based (PB) foods conferred cardiometabolic improvements.
Faecal microbiota transplantation (FMT) does not appear to have any significant effect on the cardiometabolic parameters of individuals with at least one cardiometabolic issue, according to the results of a systematic review and meta-analysis.
The novel, noninvasive ultrasound therapy is safe and may help improve valvular function in patients with calcified aortic stenosis, according to a study.
Majority of the patients with heart failure (HF) who have initiated treatment with sodium-glucose cotransporter 2 inhibitor (SGLT2i) show no change in loop diuretic dose, reports a study.
Injection with the novel, long-acting PCSK9 inhibitor recaticimab once every 3 months reduces LDL-cholesterol (LDL-C) levels by >50 percent compared with placebo in patients already maxed out on statins in the phase III REMAIN-2 trial.
Beetroot juice in combination with exercise may help improve cardiovascular function in women who are planning to have children, suggests a study.
A screening programme that incorporates artificial intelligence (AI)-guided digital stethoscope improves clinicians’ ability to detect peripartum cardiomyopathy in the Nigerian SPEC-AI trial.
Hyperuricaemia is significantly associated with the presence of increased left ventricular (LV) mass index (LVMI) in women, but not in men, reveals a recent study.